JOSEPH ORALLO: Open Payments
NPI 1306379847 · JACKSONVILLE BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,480 in 137 payments from 24 companies in 2025. Trend: 2023 $4,523 · 2024 $4,446 · 2025 $4,480
Food & beverage: $4,480
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $848 |
| Amgen Inc. | 18 | $550 |
| ABBVIE INC. | 16 | $404 |
| Novo Nordisk Inc | 11 | $402 |
| Vanda Pharmaceuticals Inc. | 14 | $301 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $287 |
| PFIZER INC. | 18 | $278 |
| Phathom Pharmaceuticals, Inc. | 3 | $199 |
| Boston Scientific Corporation | 1 | $149 |
| Daiichi Sankyo Inc. | 2 | $137 |
Products named: REPATHA, TEZSPIRE, FANAPT, CAPLYTA, BREZTRI, VOQUEZNA, VRAYLAR, Wegovy.
Industry payments across FL — which companies pay providers there.
